Jose A. Contreras, MD, FAAHPM, Hackensack University Medical Center, John Theurer Cancer Center, Chair, Institute of Pain and Palliative Medicine, Hackensack, NJ, discusses barriers to cancer pain management.
Daily aspirin use is associated with lower overall cancer mortality, but the association may be smaller than previously reported, according to a study published online Aug. 10 in the Journal of the National Cancer Institute.
For non-Hispanic whites, long-term treatment with photosensitizing antihypertensive agents correlates with an increased likelihood of lip cancer, according to a study published online Aug. 6 in the Archives of Internal Medicine.
A next-generation sequencing method is a more effective method for identifying mutations in BRCA1 and BRCA2 genes, according to a study published online Aug. 5 in The Journal of Molecular Diagnostics.
Cancer patients with an unsuspected pulmonary embolism do not have an increased mortality risk and have a similar risk of recurrent venous thromboembolism to those with clinically suspected pulmonary embolism, according to research published online July 27 in the Journal of Thrombosis and Haemostasis.
The histological subtype of renal cell carcinoma (RCC) impacts both overall and cancer-specific survival.
Higher intakes of the antioxidants selenium and vitamins C and E reduce the risk of pancreatic cancer by two-thirds.
Patients with celiac disease, particularly those presenting with malabsorption symptoms later in life, have a higher incidence of lymphoproliferative disorders (LPDs).
Compared with periprostatic nerve block (PNB), pelvic plexus block (PPB), performed under Doppler ultrasound guidance, provides better pain relief for men during office-based transrectal ultrasound-guided prostate biopsy.
A genetic score can modestly improve the prediction of which men are likely to have positive biopsies for prostate cancer after an initial negative biopsy.